Standard Chem. & Pharm. Co., Ltd.
Records under this name other than patents Standard Chem. & Pharm. Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Standard Chem. & Pharm. Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,557,784 | Glycyrrhizinates of morphinan derivatives Lapsed on the fee record Ended Oct 15, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2021 | USPTO record |
| US 8,202,995 | Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same Lapsed on the fee record Ended Jun 19, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 19, 2020 | USPTO record |
| US 8,093,260 | Aporphine derivatives and pharmaceutical use thereof Lapsed on the fee record Ended Jan 10, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 10, 2020 | USPTO record |
| US 6,726,931 | Process for preparing oral sustained-release formulation of felodipine Lapsed on the fee record Ended Apr 27, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 27, 2016 | USPTO record |
| US 6,346,269 | Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby Lapsed on the fee record Ended Feb 12, 2010 · USPTO record | Lapsed on the fee record | Ended Feb 12, 2010 | USPTO record |